drugset
drugset / Trial / NCT04789291

A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food

NCT04789291 ↗

Phase 1 Completed 13 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this trial is to investigate the relative bioavailability of BI 1595043 under fed state (Test, T) and under fasted state (Reference, R).

Timeline

Start
2021-05-18
Primary completion
2021-08-07
Completion
2021-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1595043 Unknown 30 mg —

Indications

No indication recorded.